Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg

Clinical trial NCT06348303 · COMPLETED

Trial details

NCT number: NCT06348303
Sponsor: Primus Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-05-16
Primary completion: 2024-09-05
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.